Tag Archives: Robbins Roth

Defining Specialty Pharma: What is it, Can it Innovate, and Does it Matter?

The article I wrote last week for FierceBiotech on the relationship between Series A funding and innovation led to an interesting discussion with Bruce Booth, partner at Atlas Venture and biotech blogger extraordinaire. The crux of my article was this:…